Europe — EMA
Imogaze (Simeticone)
GNH USA supplies Imogaze (Simethicone), a antifoaming agent for relief of bloating, flatulence and abdominal discomfort. Request a quote for global supply.
Request sourcing
What is Simeticone?
Simethicone, the active ingredient in Imogaze, is an antifoaming agent presented as a oral dosage form for oral use. It relieves bloating, flatulence and abdominal discomfort in adults and children.
GNH USA supplies Imogaze as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Simeticone used for?
Simethicone is an antifoaming agent that works within the gastrointestinal tract to reduce gas‑related symptoms.
Bloating: reduces abdominal distension caused by trapped gas. Flatulence: decreases the volume of intestinal gas and associated passing of wind. Gastrointestinal discomfort: alleviates pain and pressure linked to gas accumulation.
What are the side effects of Simeticone?
Simethicone is generally well tolerated, but some users may experience mild adverse reactions.
Common Side Effects: - Nausea: transient feeling of queasiness. - Belching: increased frequency of burping. - Diarrhea: mild loose stools.
Serious or Rare Side Effects: - Allergic reaction: rash, itching or swelling. - Severe abdominal pain: persistent or worsening pain. - Angioedema: swelling of face, lips or throat requiring urgent care.
What precautions apply to Simeticone?
Before using Imogaze, consider the following safety points.
Pregnancy: consult a healthcare professional before use. Breastfeeding: safety has not been established; seek medical advice. Infants and young children: use only under pediatric guidance. Hypersensitivity: avoid if known allergy to simethicone or formulation excipients. Drug interactions: discuss all concurrent medications with a prescriber. Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.
What does Simeticone interact with?
Simethicone may interact with other medicines; monitor as indicated.
Major Interactions (Avoid): - Concurrent antifoaming agents: may increase gastrointestinal side‑effects. - Medications requiring precise gastric emptying: simethicone could alter their absorption profile.
Moderate Interactions (Monitor Closely): - Antacids: timing of administration may need adjustment. - Certain antibiotics: monitor for potential reduction in efficacy. - Chemotherapy agents: observe for changes in gastrointestinal tolerance.
